Jushu Bio builds an engineering platform for microbial and mammalian chassis cells using whole‑genome editing, ultra‑high‑throughput droplet microfluidics, genome‑scale metabolic network models and deep learning. The company develops and industrializes products across healthcare, bio‑based chemicals and materials, bio‑agriculture and future foods, and aims to deliver a next‑generation CHO+microbial high‑throughput protein production platform. It operates its own R&D and production lines and has established technology and industrial collaborations with multiple listed companies and research institutions. Jushu Bio plans to focus on application development and scale production to drive industrial adoption of synthetic biology. Financially, the company has just completed a Pre‑A equity financing of over ¥100 million RMB. No revenue or user metrics were disclosed in the article.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Nov 2023